(Q38165880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

main subject

multiple drug resistance

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Golam Kibria

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hideyoshi Harashima

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

23 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

Archives of Pharmacal Research

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

4-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24272889%20AND%20SRC:MED&resulttype=core&format=json

Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model.

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Angiogenesis in human cancer: implications in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Drug resistance associated with altered DNA topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Timeline: Chemotherapy and the war on cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Metallothioneins in human tumors and potential roles in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Design considerations for tumour-targeted nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticle therapeutics: an emerging treatment modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

A multidrug resistance transporter from human MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Post-transcriptional gene silencing by siRNAs and miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Angiogenesis: an organizing principle for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

The effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticles for drug delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Openings between defective endothelial cells explain tumor vessel leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Targeting survivin in cancer: the cell-signalling perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Vaults are up-regulated in multidrug-resistant cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Overcoming cellular multidrug resistance using classical nanomedicine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Structure and function of ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Mechanisms of drug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Polymeric nanoparticles for siRNA delivery and gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanocarriers as an emerging platform for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Cancer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Subcellular localization and activity of multidrug resistance proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Cyclosporine A and adverse effects on organs: histochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Specialization of tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Quantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Metallothionein Is a Potential Negative Regulator of Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Complete regression of xenografted human carcinomas by a paclitaxel-carboxymethyl dextran conjugate (AZ10992).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

DNA amplification is rare in normal human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2

Nanoparticles in medicine: therapeutic applications and developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0276-2